MetLife Price Target Lowered to $98 by Morgan Stanley
PorAinvest
martes, 15 de julio de 2025, 7:36 pm ET1 min de lectura
JPM--
Despite the reduction in the price target, Morgan Stanley's overall outlook on MetLife remains positive, as evidenced by the continued "Overweight" rating. This rating suggests that the analysts expect MetLife's stock to perform better than the market average over the next 12 months.
The latest adjustment follows a series of updates from various analysts. Keefe, Bruyette & Woods, for instance, cut their price target for MetLife from $95.00 to $94.00, also maintaining an "outperform" rating [2]. Wells Fargo & Company raised their target price from $91.00 to $94.00, while Morgan Stanley initially boosted their target from $94.00 to $99.00. JPMorgan Chase & Co. also increased their target from $86.00 to $95.00, and Piper Sandler raised their target from $92.00 to $94.00 [2].
The consensus among analysts is that MetLife's stock is currently undervalued, with the average target price standing at $95.25, implying an upside of 22.37% from the current price of $77.84 [1]. The consensus recommendation from 17 brokerage firms is "Outperform," with an average brokerage recommendation of 2.1 [1].
MetLife's recent earnings report showed strong performance, with earnings per share (EPS) of $1.96 for the quarter, up 15.6% from the same period last year. The company also authorized a share buyback plan, indicating confidence in its stock's valuation [2]. Institutional investors have been increasing their stakes in MetLife, with several major investors boosting their positions in the second quarter [2].
References:
[1] https://www.gurufocus.com/news/2975406/met-morgan-stanley-adjusts-price-target-for-metlife-met-stock-news
[2] https://www.marketbeat.com/instant-alerts/metlife-nysemet-price-target-cut-to-9400-by-analysts-at-keefe-bruyette-woods-2025-07-09/
MET--
MS--
PIPR--
WFC--
Morgan Stanley analyst Bob Huang has lowered MetLife's (MET) price target to $98 from $99 while maintaining an Overweight rating on the shares.
Morgan Stanley analyst Bob Huang has adjusted the price target for MetLife (MET) from $99.00 to $98.00 USD, while maintaining an "Overweight" rating on the shares [1]. This adjustment reflects a slight downward revision in the projected value of MetLife's stock, indicating a 1.01% decrease in the price target.Despite the reduction in the price target, Morgan Stanley's overall outlook on MetLife remains positive, as evidenced by the continued "Overweight" rating. This rating suggests that the analysts expect MetLife's stock to perform better than the market average over the next 12 months.
The latest adjustment follows a series of updates from various analysts. Keefe, Bruyette & Woods, for instance, cut their price target for MetLife from $95.00 to $94.00, also maintaining an "outperform" rating [2]. Wells Fargo & Company raised their target price from $91.00 to $94.00, while Morgan Stanley initially boosted their target from $94.00 to $99.00. JPMorgan Chase & Co. also increased their target from $86.00 to $95.00, and Piper Sandler raised their target from $92.00 to $94.00 [2].
The consensus among analysts is that MetLife's stock is currently undervalued, with the average target price standing at $95.25, implying an upside of 22.37% from the current price of $77.84 [1]. The consensus recommendation from 17 brokerage firms is "Outperform," with an average brokerage recommendation of 2.1 [1].
MetLife's recent earnings report showed strong performance, with earnings per share (EPS) of $1.96 for the quarter, up 15.6% from the same period last year. The company also authorized a share buyback plan, indicating confidence in its stock's valuation [2]. Institutional investors have been increasing their stakes in MetLife, with several major investors boosting their positions in the second quarter [2].
References:
[1] https://www.gurufocus.com/news/2975406/met-morgan-stanley-adjusts-price-target-for-metlife-met-stock-news
[2] https://www.marketbeat.com/instant-alerts/metlife-nysemet-price-target-cut-to-9400-by-analysts-at-keefe-bruyette-woods-2025-07-09/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios